These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 17694432)

  • 1. Should a statin be prescribed to every patient with heart failure?
    Tsouli SG; Liberopoulos EN; Goudevenos JA; Mikhailidis DP; Elisaf MS
    Heart Fail Rev; 2008 Jun; 13(2):211-25. PubMed ID: 17694432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of statins in heart failure.
    Gullestad L; Oie E; Ueland T; Yndestad A; Aukrust P
    Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():35-40. PubMed ID: 18001320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Statin Treatment on Inflammation and Cardiac Function in Heart Failure: An Adjusted Indirect Comparison Meta-Analysis of Randomized Trials.
    Bonsu KO; Reidpath DD; Kadirvelu A
    Cardiovasc Ther; 2015 Dec; 33(6):338-46. PubMed ID: 26280110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins in heart failure. Beyond the lipid lowering effect.
    Tousoulis D; Charakida M; Stefanadi E; Siasos G; Latsios G; Stefanadis C
    Int J Cardiol; 2007 Feb; 115(2):144-50. PubMed ID: 17175040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins in heart failure--With preserved and reduced ejection fraction. An update.
    Tousoulis D; Oikonomou E; Siasos G; Stefanadis C
    Pharmacol Ther; 2014 Jan; 141(1):79-91. PubMed ID: 24022031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin use in heart failure: a cause for concern?
    Raina A; Pickering T; Shimbo D
    Am Heart J; 2006 Jul; 152(1):39-49. PubMed ID: 16824830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins in heart failure-where do we stand?
    Lyons KS; McVeigh GE; Harbinson MT
    Cardiovasc Drugs Ther; 2011 Feb; 25(1):99-104. PubMed ID: 21136284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipophilic versus hydrophilic statin therapy for heart failure: a protocol for an adjusted indirect comparison meta-analysis.
    Bonsu KO; Kadirvelu A; Reidpath DD
    Syst Rev; 2013 Apr; 2():22. PubMed ID: 23618535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between use of statins and outcomes in heart failure with reduced ejection fraction: prospective propensity score matched cohort study of 21 864 patients in the Swedish Heart Failure Registry.
    Alehagen U; Benson L; Edner M; Dahlström U; Lund LH
    Circ Heart Fail; 2015 Mar; 8(2):252-60. PubMed ID: 25575580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do statins reduce the risk of myocardial infarction in patients with heart failure? A pooled individual-level reanalysis of CORONA and GISSI-HF.
    Feinstein MJ; Jhund P; Kang J; Ning H; Maggioni A; Wikstrand J; Kjekshus J; Tavazzi L; McMurray J; Lloyd-Jones DM
    Eur J Heart Fail; 2015 Apr; 17(4):434-41. PubMed ID: 25684642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Statins in Heart Failure with Preserved Ejection Fraction: Current Evidence and Perspectives.
    Ovchinnikov A; Potekhina A; Arefieva T; Filatova A; Ageev F; Belyavskiy E
    Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of statin use and clinical outcomes in heart failure patients: a systematic review and meta-analysis.
    Bielecka-Dabrowa A; Bytyçi I; Von Haehling S; Anker S; Jozwiak J; Rysz J; Hernandez AV; Bajraktari G; Mikhailidis DP; Banach M
    Lipids Health Dis; 2019 Oct; 18(1):188. PubMed ID: 31672151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of the survival benefit associated with statins in patients with acute heart failure.
    Park CS; Hwang IC; Park JJ; Park JH; Park JB; Cho GY
    ESC Heart Fail; 2021 Dec; 8(6):5424-5435. PubMed ID: 34612019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipids, Statins and Heart Failure: An Update.
    Katsiki N; Doumas M; Mikhailidis DP
    Curr Pharm Des; 2016; 22(31):4796-4806. PubMed ID: 27396601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins in non-ischaemic cardiomyopathy: an update on our current clinical and pathophysiological understanding.
    Verma N; Figueredo VM
    Int J Clin Pract; 2011 Nov; 65(11):1156-64. PubMed ID: 21851514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure.
    Horwich TB; MacLellan WR; Fonarow GC
    J Am Coll Cardiol; 2004 Feb; 43(4):642-8. PubMed ID: 14975476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of lipophilic statins for heart failure: a meta-analysis of 13 randomised controlled trials.
    Liu G; Zheng XX; Xu YL; Lu J; Hui RT; Huang XH
    Heart Lung Circ; 2014 Oct; 23(10):970-7. PubMed ID: 24954758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipophilic Statin Versus Rosuvastatin (Hydrophilic) Treatment for Heart Failure: a Meta-Analysis and Adjusted Indirect Comparison of Randomised Trials.
    Bonsu KO; Reidpath DD; Kadirvelu A
    Cardiovasc Drugs Ther; 2016 Apr; 30(2):177-88. PubMed ID: 26780905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMG-CoA reductase inhibitors in chronic heart failure: potential mechanisms of benefit and risk.
    Laufs U; Custodis F; Böhm M
    Drugs; 2006; 66(2):145-54. PubMed ID: 16451090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender differences in statin prescription rates, adequacy of dosing, and association of statin therapy with outcome after heart failure hospitalization: a retrospective analysis in a community setting.
    Ballo P; Balzi D; Barchielli A; Turco L; Franconi F; Zuppiroli A
    Eur J Clin Pharmacol; 2016 Mar; 72(3):311-9. PubMed ID: 26581760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.